AAAAAA
Results: 51-75/108
Authors:
Briones, C
Soriano, V
Gonzalez-Lahoz, J
Citation: C. Briones et al., Prevalence of drug-resistant HIV-1 genotypes in heavily pre-treated patients on current virological failure, AIDS, 14(11), 2000, pp. 1659-1660
Authors:
Soriano, V
Dona, C
Barreiro, P
Gonzalez-Lahoz, J
Citation: V. Soriano et al., Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?, AIDS, 14(11), 2000, pp. 1672-1673
Authors:
Mas, A
Parera, M
Briones, C
Soriano, V
Martinez, MA
Domingo, E
Menendez-Arias, L
Citation: A. Mas et al., Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance, EMBO J, 19(21), 2000, pp. 5752-5761
Authors:
Briones, C
Mas, A
Gomez-Mariano, G
Altisent, C
Menedez-Arias, L
Soriano, V
Domingo, E
Citation: C. Briones et al., Dynamics of dominance of a dipeptide insertion in reverse transcriptase ofHIV-1 from patients subjected to prolonged therapy, VIRUS RES, 66(1), 2000, pp. 13-26
Authors:
Soriano, V
Gomes, P
Heneine, W
Holguin, A
Doruana, M
Antunes, R
Mansinho, K
Switzer, WM
Araujo, C
Shanmugam, V
Lourenco, H
Gonzalez-Lahoz, J
Antunes, F
Citation: V. Soriano et al., Human immunodeficiency virus type 2 (HIV-2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load, J MED VIROL, 61(1), 2000, pp. 111-116
Authors:
Rodes, B
Holguin, A
Soriano, V
Dourana, M
Mansinho, K
Antunes, F
Gonzalez-Lahoz, J
Citation: B. Rodes et al., Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy, J CLIN MICR, 38(4), 2000, pp. 1370-1374
Authors:
Lerma, JGG
Soriano, V
Mas, A
Quinones-Mateu, ME
Arts, EJ
Heneine, W
Citation: Jgg. Lerma et al., Quantitation of human immunodeficiency virus type 1 group O load in plasmaby measuring reverse transcriptase activity, J CLIN MICR, 38(1), 2000, pp. 402-405
Authors:
Dona, C
Soriano, V
Barreiro, P
Jimenez-Nacher, I
Gonzalez-Lahoz, J
Citation: C. Dona et al., Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program, MED CLIN, 115(9), 2000, pp. 337-338
Authors:
Nunez, M
Soriano, V
Citation: M. Nunez et V. Soriano, Cancer and HIV in the combined therapy era, MED CLIN, 115(3), 2000, pp. 93-94
Authors:
Martin, JC
Fernandez, P
Soriano, V
Martinez, P
Gonzalez-Lahoz, J
Citation: Jc. Martin et al., Viral load and CD4+lymphocyte count in the highly active antiretroviral therapy era, MED CLIN, 115(3), 2000, pp. 118-118
Authors:
Holguin, A
Soriano, V
Citation: A. Holguin et V. Soriano, Origin and evolution of human immunodeficiency virus, MED CLIN, 115(20), 2000, pp. 775-778
Authors:
del Amo, J
Perez-Hoyos, S
Aguado, IH
Muga, R
Egea, JM
Clotet, B
Tor, J
Ruiz, I
Tussell, J
Lorenzo, JI
del Romero, J
Barrasa, A
Rodriguez, C
Castilla, J
Garcia, S
Diez, M
Soriano, V
del Amo, J
Avino, J
Aracil, JG
Garcia, M
Brugal, T
Cayla, J
de Olaya, PG
Citation: J. Del Amo et al., AIDS incubation period in Spain before highly active antiretreviral therapy, MED CLIN, 115(18), 2000, pp. 681-686
Authors:
Rodriguez-Rosado, R
Soriano, V
Citation: R. Rodriguez-rosado et V. Soriano, Intensified anti-retroviral therapy, REV CLIN ES, 200(2), 2000, pp. 84-87
Authors:
Soriano, V
Rodriguez-Rosado, R
Lahoz, JG
Citation: V. Soriano et al., Rescue anti-retroviral therapy, REV CLIN ES, 200(2), 2000, pp. 88-94
Authors:
Dauman, R
Daubech, Q
Gavilan, I
Colmet, L
Delaroche, M
Michas, N
Baldet, F
Saget, F
Diallo, A
Duriez, F
Olegaray, F
Soriano, V
Debruge, E
Citation: R. Dauman et al., Long-term outcome of childhood hearing deficiency, ACT OTO-LAR, 120(2), 2000, pp. 205-208
Authors:
Perez-Olmeda, M
Gonzalez, J
Garcia-Samaniego, J
Arribas, JR
Soriano, V
Citation: M. Perez-olmeda et al., Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C, J ACQ IMM D, 22(3), 1999, pp. 308-309
Authors:
Perez-Olmeda, M
Rubio, A
Puig, T
Gomez-Cano, M
Ruiz, L
Leal, M
Clotet, B
Soriano, V
Citation: M. Perez-olmeda et al., Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimens, ANTIVIR TH, 4(3), 1999, pp. 179-181
Authors:
Soriano, V
Citation: V. Soriano, Prevalence of drug resistance mutations in Spain among both naive and pretreated patients, ANTIVIR TH, 4, 1999, pp. 57-63
Authors:
Gomez-Cano, M
Rubio, A
Ruiz, L
Perez-Olmeda, M
Leal, M
Clotet, B
Soriano, V
Citation: M. Gomez-cano et al., Efficiency of drug resistance genotypic tests in specimens with low HIV viral load, ANTIVIR TH, 4(2), 1999, pp. 123-124
Authors:
Briones, C
Soriano, V
Citation: C. Briones et V. Soriano, Different outcome in the first two patients with an HIV-1 multinucleoside drug-resistant T69SSS insertion in Spain, ANTIVIR TH, 4(2), 1999, pp. 125-127
Authors:
Lin, PF
Gonzalez, CJ
Griffith, B
Friedland, G
Calvez, V
Ferchal, F
Schinazi, RF
Shepp, DH
Ashraf, AB
Wainberg, MA
Soriano, V
Mellors, JW
Colonno, RJ
Citation: Pf. Lin et al., Stavudine resistance: an update on susceptibility following prolonged therapy, ANTIVIR TH, 4(1), 1999, pp. 21-28
Authors:
Rubio, A
Gomez-Cano, M
Puig, T
Leal, M
Perez-Olmeda, M
Ruiz, L
Clotet, B
Rey, C
Zamora, L
Xaus, N
Soriano, V
Citation: A. Rubio et al., Presence of genotypic resistance in nucleoside analogue-treated HIV-1-infected patients with undetectable viral load, ANTIVIR TH, 4(1), 1999, pp. 45-49
Authors:
de Mendoza, C
Soriano, V
Perez-Olmeda, M
Rodes, B
Casas, E
Gonzalez-Lahoz, J
Citation: C. De Mendoza et al., Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy, J HUMAN VIR, 2(6), 1999, pp. 344-349
Authors:
Fernandez, J
Blanca, M
Soriano, V
Sanchez, J
Juarez, C
Citation: J. Fernandez et al., Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area, CLIN EXP AL, 29(8), 1999, pp. 1069-1074
Authors:
Rodriguez-Rosado, R
Soriano, V
Blanco, F
Dona, C
Gonzalez-Lahoz, J
Citation: R. Rodriguez-rosado et al., Diabetes mellitus associated with protease inhibitor use, EUR J CL M, 18(9), 1999, pp. 675-677